🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Wall Street set to rebound after rout spurred by inflation, Omicron

Published 2021-12-01, 07:01 a/m
© Reuters. FILE PHOTO: A Wall Street sign is pictured outside the New York Stock Exchange amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., April 16, 2021. REUTERS/Carlo Allegri/File Photo
DJI
-
MSFT
-
GOOGL
-
AAPL
-
AMZN
-
OXY
-
CRM
-
ESU24
-
1YMU24
-
NQU24
-
TSLA
-
CCL
-
GOOG
-

By Devik Jain and Ambar Warrick

(Reuters) -Wall Street's main indexes were set to bounce back on Wednesday following a sharp sell-off triggered by concerns over rising inflation and the new Omicron coronavirus variant, while shares of Merck rose on progress in the approval of its COVID-19 pill.

Merck & Co Inc gained 1.1% in premarket trading after a panel of advisers to the U.S. Food and Drug Administration narrowly voted to recommend the agency authorize the drugmaker's antiviral pill to treat COVID-19.

U.S. stocks slumped on Tuesday after Federal Reserve Chair Jerome Powell in his testimony before the Senate Banking Committee indicated that he no longer considers inflation as "transitory".

Powell also said the U.S. central bank would consider bringing forward plans for tapering its bond buying program at its next meeting in two weeks.

"Most investors realized that the Fed was going to have to shift course somewhat ... there's plenty of people that feel inflation is a bigger problem, and maybe a bigger risk to the market would be the Fed failing to take any action that recognizes that," said Rick Meckler, partner, Cherry Lane Investments in New Vernon, New Jersey.

"Coming to the year-end, where markets can be a little less liquid, we are likely to see some back and forth until we get more information (on Omicron)."

Investors were also awaiting a Fed report, known as the "Beige Book", on current economic conditions to provide further insight into the central bank's stance on inflation. The report is due at 2:00 p.m. ET (1900 GMT).

Powell's seemingly hawkish comments on Tuesday served as a double whammy for markets, which were already nervous about the spread of the Omicron variant and its potential to hinder a global economic recovery.

The Fed chair is also due to testify before a House Financial Services Committee hearing at 10 a.m. ET.

A World Health Organization official said some of the early indications were that most Omicron cases were mild, with none severe.

Travel and leisure stocks rebounded, with cruiseliners Norwegian Cruise Line, Carnival (NYSE:CCL) Corp and Royal Caribbean rising between 2.2% and 3.2%.

Occidental Petroleum (NYSE:OXY), which led gains among energy stocks, was up 3.4% as oil prices climbed 3%. Shares of major Wall Street lenders also moved higher after steep falls on Tuesday. [O/R]

At 8:20 a.m. ET, Dow e-minis were up 300 points, or 0.87%.

The S&P 500 e-minis were up 55.5 points, or 1.22%, and Nasdaq 100 e-minis were up 212.5 points, or 1.32%, supported by shares of Amazon.com (NASDAQ:AMZN), Apple Inc (NASDAQ:AAPL), Tesla Inc (NASDAQ:TSLA), Google owner Alphabet (NASDAQ:GOOGL) Inc, Meta Platforms and Microsoft Corp (NASDAQ:MSFT). All these tech companies added between 1.2% and 1.7%.

© Reuters. FILE PHOTO: A Wall Street sign is pictured outside the New York Stock Exchange amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., April 16, 2021. REUTERS/Carlo Allegri/File Photo

Meanwhile, data showed U.S. private employers maintained a strong pace of hiring in November. Readings on manufacturing activity are due after market open.

Salesforce.com Inc (NYSE:CRM) forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 6.2%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.